The results of the Elispot harmonization efforts of the Cancer Immunotherapy Consortium (CIC/CRI), in collaboration with European Association of Immunotherapy of Cancer (CIMT), have led to guidelines for the evaluation of Elispot plates, based on a large Elispot plate reading panel and consensus process involving more than 100 scientists from all over the world. The guidelines have recently been published in Nature Protocols.